FRISINA, Nicola
 Distribuzione geografica
Continente #
EU - Europa 7.848
NA - Nord America 6.284
AS - Asia 3.698
SA - Sud America 1.253
AF - Africa 93
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 19.185
Nazione #
US - Stati Uniti d'America 6.162
RU - Federazione Russa 4.004
SG - Singapore 1.466
CN - Cina 1.244
BR - Brasile 1.077
SE - Svezia 959
IE - Irlanda 917
DE - Germania 564
UA - Ucraina 398
HK - Hong Kong 386
FI - Finlandia 257
FR - Francia 235
VN - Vietnam 221
GB - Regno Unito 205
IT - Italia 142
IN - India 88
CA - Canada 65
AR - Argentina 54
TR - Turchia 45
PL - Polonia 41
BD - Bangladesh 38
EC - Ecuador 31
IQ - Iraq 31
VE - Venezuela 31
MX - Messico 30
BE - Belgio 29
ZA - Sudafrica 26
JP - Giappone 22
CZ - Repubblica Ceca 19
PK - Pakistan 18
CO - Colombia 16
IR - Iran 16
MA - Marocco 16
UY - Uruguay 14
AT - Austria 13
ID - Indonesia 13
UZ - Uzbekistan 13
KE - Kenya 11
NP - Nepal 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
EG - Egitto 10
JO - Giordania 10
NL - Olanda 10
CL - Cile 9
ES - Italia 9
PE - Perù 9
AZ - Azerbaigian 7
CI - Costa d'Avorio 7
DO - Repubblica Dominicana 6
KG - Kirghizistan 6
KZ - Kazakistan 6
LT - Lituania 6
PA - Panama 6
BG - Bulgaria 5
BO - Bolivia 5
CR - Costa Rica 5
IL - Israele 5
OM - Oman 5
PY - Paraguay 5
SA - Arabia Saudita 5
SN - Senegal 5
AL - Albania 4
CH - Svizzera 4
JM - Giamaica 4
MY - Malesia 4
RO - Romania 4
AU - Australia 3
DK - Danimarca 3
EE - Estonia 3
EU - Europa 3
GE - Georgia 3
HN - Honduras 3
MN - Mongolia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
PH - Filippine 3
RS - Serbia 3
BN - Brunei Darussalam 2
GR - Grecia 2
GT - Guatemala 2
GY - Guiana 2
KR - Corea 2
LK - Sri Lanka 2
LV - Lettonia 2
PS - Palestinian Territory 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CY - Cipro 1
DZ - Algeria 1
GI - Gibilterra 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
Totale 19.175
Città #
Moscow 1.154
Dublin 917
Jacksonville 848
Singapore 782
Chandler 778
Ashburn 759
Dallas 614
Nyköping 456
Beijing 432
Hong Kong 384
San Jose 250
The Dalles 197
Munich 177
Los Angeles 162
Cambridge 150
Princeton 150
Lauterbourg 141
Medford 141
Des Moines 120
Ann Arbor 114
Boardman 108
New York 106
Dearborn 86
São Paulo 74
Ho Chi Minh City 71
Helsinki 70
Buffalo 62
Lancaster 61
Bremen 52
Hanoi 52
Tianjin 51
Shenyang 48
Guangzhou 47
Jinan 47
Wilmington 47
Woodbridge 45
Frankfurt am Main 39
Santa Clara 34
Turku 34
Redondo Beach 33
Zhengzhou 32
Belo Horizonte 30
Rio de Janeiro 30
Brussels 28
Hebei 28
Orem 27
San Mateo 27
Nanjing 26
Houston 24
Warsaw 24
Turin 23
Montreal 22
Pune 22
Taizhou 22
Haikou 21
Shanghai 21
Johannesburg 20
Tokyo 20
Chennai 19
Hangzhou 19
Ningbo 19
Augusta 18
Boston 18
Düsseldorf 18
Ottawa 18
Curitiba 17
Poplar 17
Porto Alegre 17
San Francisco 17
Seattle 17
Brno 16
Campinas 15
London 15
Mumbai 15
Stockholm 15
Atlanta 14
Denver 14
Quito 14
Baghdad 13
Changsha 13
Lanzhou 13
Taiyuan 13
Brooklyn 12
Guayaquil 12
Nanchang 12
Santo André 12
Chicago 11
Falls Church 11
Jiaxing 11
Shenzhen 11
Amman 10
Ardabil 10
Brasília 10
Istanbul 10
Leawood 10
Nuremberg 10
Recife 10
Tashkent 10
Da Nang 9
Fuzhou 9
Totale 10.914
Nome #
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 290
Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study 230
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 214
Bone remodeling and regulation of sRANKL/OPG balance after genistein administration in osteopenic, postmenopausal women 202
Recombinant human erythropoietin stimulates angiogenesis and healing of ischemic skin wounds 201
Cell proliferation/cell death balance in renal cell cultures after exposure to a static magnetic field 200
AQP1 in red blood cells of uremic patients during hemodialytic treatment 195
Behavior of vascular endothelial growth factor and erythropoietin throughout the menstrual cycle in healthy women. 194
Aquaporin-2 water channels in spontaneously hypertensive rats 192
Circadian rhythm of hydration in healthy subjects and uremic patients studied by bioelectrical impedance analysis 187
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 187
Administration of recombinant erythropoietin determines increase of peripheral resistances in patients with hypovolemic shock 186
ASSETTO EMATOLOGICO DI UN GRUPPO DI SOGGETTIAFFETTI DA MORBO DI COOLEY:STUDIO DEL COMPORTAMENTO DELL'ERITROPOIETINA PLASMATICA 185
Alterations in induced potassium calcium efflux in the erythrocytes of patients with autosomal dominant polycystic kidney disease and hypertension 182
Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study 181
Does captopril have a direct pro-apoptotic effect? 181
Are there potential non-lipid-lowering uses of statins in the kidney? 179
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. 178
Oxidative stress, sister chromatid exchanges and apoptosis in the pathogenesis of lymphocytopenia in ESRD patients 178
Cardiovascular effects of raloxifene hydrochloride 177
Effects of Homocysteine on Proliferation, Necrosis, and Apoptosis of Vascular Smooth Muscle Cells in Culture and Influence of Folic Acid 176
Bisphosphonates in the treatment of thalassemia-induced osteoporosis 175
Onset of hypothyroidism with polymyositis-like clinical features in elderly patients 173
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study 173
Correlation between quality of life assessment and a personality neurobiologic model in dialyzed patients 172
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 171
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo controlled study. 169
Association of primary hyperparathyoidism (p-hyperPTH) with nodular toxic goiter (NTG): a prospective study at an outpatient osteoporosis service. 167
Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin 167
Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study 165
A trigonometric approximation method for the monostatic radar cross section 165
Cardiorenal consequences of atherosclerosis and statins therapy: From the past to the future 161
Association between primary hyperprathyroidism (p-hyperPTH) and nodular toxic goiter (NTG): a prospective study at an outpatient service for osteoporosis 160
Recombinant erythropoietin and hypertension 160
Chromosomal damage and atherosclerosis. A protective effect from simvastatin. 160
Cold pressor test raises serum concentrations of ICAM-1, VCAM- 1, and E-selectin in normotensive and hypertensive patients 158
Effetti dell'alendronato sul Sister Chromatid Exchanges (SCE) in pazienti con osteoporosi post-menopausale (dati preliminari). 158
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 158
Effect of two different models of hemodiafiltration potassium removal on QT dispersion 155
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 153
Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 year randomized, placebo-controlled study 151
Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women - A randomized trial 150
Effect of interleukin 8 and ICAM-1 on calcium-dependent outflow of K+ in erythrocytes from subjects with essential hypertension 148
Hashimoto's thyroiditis is a frequent association of primary hyperparathyroidism, of which it modifies biochemical and bone density indices 148
The effect of two different protocols of potassium haemodiafiltration on QT dispersion 148
Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and Placebo-controlled Study 148
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappa B ligand-osteoprotegerin system in early postmenopausal women 148
Aldosterone and prolactin secretion. II. Plasma renin activity, blood potassium and cortisol levels following administration of sulpiride in normal subjects 145
Oxidative stress and uremia 145
Hashimoto's thyroiditis (HT) is a frequent association of primary hyperparathyroidism (p-hyperPTH), of which it modifies biochemical and bone density indices 144
EFFICACY AND TOLERABILITY OF AURANOFIN IN RHEUMATOID-ARTHRITIS - 2 YEARS FOLLOW-UP 144
Effetti di un fitoestrogeno (Genisteina) su marcatori citogenetici in donne in post menopausa. 143
Therapy with vasopressin receptor antagonists: the aquaretics 143
Statins in the prevention of cardiovascular events in patients with renal failure. 142
Hypokalemic myopathy in pseudohyperaldosteronism induced by fluoroprednisolone-containing nasal spray. 142
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study 142
Effect of a prostacyclin analogue, iloprost, on urinary aquaporin-2 excretion in humans 142
Genistein effects on quantitative ultrasound parameters and bone mineral density in osteopenic postmenopausal women 142
Hemostasis and fibrinolysis factors in first-degree relatives of patients with type 2 diabetes without hypertension 141
Effect of unsaturated fatty acids on basal plasma renin activity and afterpostural stimulation 140
The behaviour of serum triiodothyronine in autonomous thyroid nodules and its relationship with the clinical feature 140
Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: New pieces of the puzzle 140
Nonrobertsonian translocation t(6;11) is associated with infertility in an oligoazoospermic male 139
L'azione di un bolo di rHu-EPO sul flusso muscolare di soggetti uremici 139
ATTIVITÀ RENINICA, ANGIOTENSINA II, ALDOSTERONE PLASMATICI IN SOGGETTI ANZIANI. 139
Effect of long-term treatment with Raloxifene on mammary density in postmenopausal women. 138
Erythropoietin and the brain: from neurodevelopment to neuroprotection 138
Increased indexes of thrombin activation in advanced stages of hypertension 138
Statins in nephrotic syndrome: a new weapon against tissue injury. 137
Cardiovascular remodeling, apoptosis, and drugs 137
SICUREZZA ED EFFICACIA DELLA GENISTEINA IN DONNE OSTEOPENICHE IN POSTMENOPAUSA 136
Osteoporosis and beta-thalassemia major: Role of the IGF- I/IGFBP-III axis 135
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis 135
Statins and progressive renal disease 134
Effects of lisinopril administration on blood bcl-2 concentrations in patients with immunoglobulin A nephropathy 133
Osteoprotegerin, IL-6, IL-1, TNF-alpha and TGF-beta concentrations during acetate-free biofiltration 130
Kidney aging: From phenotype to genetics 130
Effetti del raloxifene sulla secrezione ipofisaria in post-menopausa 129
The pleiotropic effects of erythropoietin in the central nervous system 128
Effect of genistein on endothelial function in postmenopausal women: A randomized, double-blind, controlled study 127
Reduced bcl-2 concentrations in hypertensive patients after lisinopril or nifedipine administration 126
ELIZABETHAN STUDIES IN ITALY IN 1989 AND 1990 125
Management of patients after renal graft loss: an open question for nephrologists. 125
THE CIRCADIAN-RHYTHM OF ERYTHROPOIETIN IN SUBJECTS WITH PRE- TERMINAL UREMIA 122
Preventing bone loss during androgen deprivation therapy for prostate cancer: Early experience with neridronate. EUROPEAN UROLOGY, vol. 47; p. 575 - 581 122
Gastro-intestinal permeability is increased in patients with limited systemic sclerosis 121
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 116
Loss of circadian rhythm in erythropoietin production in a patient with renal erythropoietin secreting neoplasia 116
DOES ERYTHROPOIETIN AUGMENT THE CA2+-MEDIATED K+ FLOW INTO THE RED-BLOOD-CELLS IN NORMOTENSIVE AND HYPERTENSIVE SUBJECTS 113
Effect of a calcium antagonist, nifedipine, on the cold pressor test in normal subjects 112
From the oxygen to the organ protection: erythropoietin as protagonist in internal medicine 110
Recombinant human erythropoietin (rHuEPO): More than just the correction of uremic anemia 107
Does erythropoietin administration affect progression of atherosclerosis in Watanabe heritable hyperlipaemic rabbits? 107
Plasma and erythrocyte magnesium concentrations in essential arterial hypertension 106
Flushing due to calcitonin and the opioid system 105
Intravenous recombinant erythropoietin does not lead to an increase in cerebrospinal fluid erythropoietin concentration 103
Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major 103
Effect of Growth Factors on the Potassium-Calcium induced efflux in vitro in wlole erythrocytes from hypertensive and pregnant subjects with gestation hypertension 102
Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients 100
DIFFERENT ANSWER TO RECOMBINANT-HUMAN-ERYTHROPOIETIN IN ANEPHRIC AND NONANEPHRIC HEMODIALYZED PATIENTS 100
Totale 15.054
Categoria #
all - tutte 60.486
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.486


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021235 0 0 0 0 0 0 0 0 0 69 124 42
2021/20221.213 5 263 13 26 62 10 59 39 56 225 133 322
2022/20232.829 203 272 128 221 251 279 25 193 1.107 34 85 31
2023/2024619 48 99 41 58 35 154 26 34 4 35 9 76
2024/20253.105 60 25 46 189 114 132 92 695 762 188 306 496
2025/20268.510 437 650 592 592 661 1.943 1.010 1.137 1.226 262 0 0
Totale 19.246